Metastatic prostate cancer‐derived extracellular vesicles facilitate osteoclastogenesis by transferring the CDCP1 protein
Journal of Extracellular Vesicles · 2023-03 · 12 (3)
DOI: 10.1002/jev2.12312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 07.03.2023. Verfasst von Fumihiko Urabe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Extracellular Vesicles, Prostatic Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Japanese Urological Association.
Abstract (Originalsprache)
Bone metastases are still incurable and result in the development of clinical complications and decreased survival for prostate cancer patients. Recently, a number of studies have shown that extracellular vesicles (EVs) play important roles in tumour progression. Here, we show that EVs from metastatic prostate cancer cells promote osteoclast formation in the presence of receptor activator of NF‐κB ligand (RANKL). EV characterization followed by functional siRNA screening identified CUB‐domain containing protein 1 (CDCP1), a transmembrane protein, as an inducer of osteoclastogenesis. Additionally, CDCP1 expression on plasma‐derived EVs was upregulated in bone metastatic prostate cancer patients. Our findings elucidate the effect of EVs from metastatic prostate cancer cells on osteoclast formation, which is promoted by CDCP1 located on EVs. Furthermore, our data suggested that CDCP1 expression on EVs might be useful to detect bone metastasis of prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
- Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan.
- Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.
- R&D Division, Kewpie Corporation Sengawa Kewport, Tokyo, Japan.
- School of Biomedical Sciences, Faculty of Medicine, University of Queensland, Brisbane, Australia.
ORCID-Profile: Fumihiko Urabe, Carolina Soekmadji, Takahiro Ochiya
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Japanese Urological Association
- Japanese Foundation for Prostate Research
- U.S. Department of Defense
Zitieren
APA
Urabe, F., Kosaka, N., Yamamoto, Y., Ito, K., Otsuka, K., Soekmadji, C., Egawa, S., Kimura, T., & Ochiya, T. (2023). Metastatic prostate cancer‐derived extracellular vesicles facilitate osteoclastogenesis by transferring the CDCP1 protein. Journal of Extracellular Vesicles, 12(3). https://doi.org/10.1002/jev2.12312
Vancouver
Urabe F, Kosaka N, Yamamoto Y, Ito K, Otsuka K, Soekmadji C, et al. Metastatic prostate cancer‐derived extracellular vesicles facilitate osteoclastogenesis by transferring the CDCP1 protein. Journal of Extracellular Vesicles. 2023;12(3). doi:10.1002/jev2.12312
BibTeX
@article{Urabe2023,
author = {Urabe, Fumihiko and Kosaka, Nobuyoshi and Yamamoto, Yusuke and Ito, Kagenori and Otsuka, Kurataka and Soekmadji, Carolina and Egawa, Shin and Kimura, Takahiro and Ochiya, Takahiro},
title = {Metastatic prostate cancer‐derived extracellular vesicles facilitate osteoclastogenesis by transferring the CDCP1 protein},
journal = {Journal of Extracellular Vesicles},
year = {2023},
volume = {12},
number = {3},
doi = {10.1002/jev2.12312}
}
EUVIMED